Hiroaki Iwaki

Title: Hiroaki Iwaki: Innovator in Biochemical Engineering

Introduction

Hiroaki Iwaki is a prominent inventor based in Montreal, Canada. He has made significant contributions to the field of biochemical engineering, particularly in the area of monooxygenases. With a total of 4 patents to his name, Iwaki's work has advanced our understanding of microbial degradation pathways.

Latest Patents

Iwaki's latest patents include groundbreaking inventions such as the recombinant cyclopentanone monooxygenase (CPMO) and the gene encoding cyclododecanone monooxygenase. The CPMO, derived from a specific bacterial strain, plays a crucial role in the degradation of cyclopentanol, allowing the bacterium to utilize it as a sole carbon source for growth. His research has identified the localization of the CPMO-encoding gene and detailed the sequence of the 550-amino acid CPMO polypeptide. Additionally, his work on the cyclododecanone monooxygenase involves the isolation, cloning, and sequencing of a new gene, which has potential applications in various biotechnological processes.

Career Highlights

Hiroaki Iwaki is affiliated with the National Research Council of Canada, where he continues to push the boundaries of research in his field. His innovative approaches and dedication to scientific inquiry have positioned him as a leading figure in biochemical research.

Collaborations

Iwaki has collaborated with notable colleagues such as Yoshie Hasegawa and Peter C K Lau, contributing to a rich environment of shared knowledge and expertise.

Conclusion

Hiroaki Iwaki's contributions to the field of biochemical engineering through his patents and research are invaluable. His work not only enhances our understanding of microbial processes but also paves the way for future innovations in biotechnology.